1099-1557/asset/PDS_left.gif?v=1&s=f962ae698249deba4dc56217f1bb95eac528fe4d)
1099-1557/asset/PDS_right.gif?v=1&s=44103455c6e4e28135198609bb6a426efee9a51c)
Original Report
You have free access to this content
Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data
Article first published online: 19 JAN 2012
DOI: 10.1002/pds.2324
Copyright © 2012 John Wiley & Sons, Ltd.
Issue
Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 62–71, January 2012
Additional Information
How to Cite
Nelson, J. C., Cook, A. J., Yu, O., Dominguez, C., Zhao, S., Greene, S. K., Fireman, B. H., Jacobsen, S. J., Weintraub, E. S. and Jackson, L. A. (2012), Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data. Pharmacoepidem. Drug Safe., 21: 62–71. doi: 10.1002/pds.2324
Publication History
- Issue published online: 19 JAN 2012
- Article first published online: 19 JAN 2012
Funded by
- FDA through the Department of Health and Human Services. Grant Number: HHSF223200910006I
REFERENCES
- 1, , , et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000; 78(2): 186–194.
- 2, , , et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 2005; 16: 336–341. DOI: 10.1097/01.ede.0000155506.05636.a4
- 3, , , et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 2011; 127: S45–S53.
- 4, , , et al. Developing the Sentinel System — A National Resource for Evidence Development. N Engl J Med 2011; 364: 498–499.
- 5, , , et al. Methods for observational post-licensure medical product safety surveillance. Stat Methods Med Res (in press).
- 6, , , et al. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Seq Anal 2011; 30: 58–78.
- 7, , , et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007; 45(10): S89–95. DOI: 10.1097/MLR.0b013e3180616c0a
- 8, , , et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 2009; 27: 4257–4262. DOI: 10.1016/j.vaccine.2009.05.036
- 9, , , et al. on behalf of the Vaccine Safety Datalink Investigation Group. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010; 29(1): 1–5. DOI: 10.1097/INF.0b013e3181af8605
- 10, , , et al. Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures. Pediatrics 2010; 126: e1–e8. DOI: 10.1542/peds.2010-0665
- 11, , , et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol 2010; 171(2): 177–88. DOI: 10.1093/aje/kwp345
- 12, , , et al. Update: Recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep 2008; 57: 258–260.
- 13, , , et al. on behalf of the Vaccine Safety Datalink Project. H1N1 and seasonal influenza vaccine safety using prospective weekly surveillance in the Vaccine Safety Datalink Project. Am J Prev Med 2011; 41: 121–128.
- 14. The design and analysis of sequential clinical trials. Wiley: New York, NY, 1997.
- 15, . Group sequential methods with applications to clinical trials. CRC Press: Boca Raton, FL, 2000.
- 16. A conditional sequential sampling procedure for drug safety surveillance. Stat Med 2009; 28: 3124–3138. DOI: 10.1002/sim.3689
- 17, , , et al. Statistical approaches to group sequential monitoring of postmarketing safety surveillance data: Current state of the art for use in the Mini-Sentinel surveillance project. Pharmacoepidemiol Drug Saf 2012; 21(S1): 72–81.
- 18Centers for Disease Control and Prevention. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, and Haemophilus b Conjugate Vaccine and Guidance for Use in Infants and Children. MMWR Morb Mortal Wkly Rep 2008; 57(39): 1079–1080.
- 19, , , et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007; 16(12): 1275–1284. DOI: 10.1002/pds.1509
- 20, , , et al. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf 2009; 18(3): 226–234. DOI: 10.1002/pds.1706
- 21, , . Frequentist evaluation of group sequential clinical trial designs. Stat Med 2007; 26: 5047–5080. DOI: 10.1002/sim.2901
- 22, , , et al. Study design considerations in an active medical product safety monitoring system. Pharmacoepidemiol Drug Saf 2012; 21(S1): 32–40.
- 23. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64(2): 191–199. DOI: 10.1093/biomet/64.2.191
- 24, . Group Sequential Clinical Trials with Triangular Continuation Regions. Biometrics 1983; 39: 227–236.
- 25, . A Multiple Testing Procedure for Clinical Trials. Biometrics 1979; 35: 549–556.
- 26, . Approximately Optimal One-Parameter Boundaries for Group Sequential Trials. Biometrics 1987; 43: 193–199.
- 27, . A unifying family of group sequential test designs. Biometrics 1999; 55(3): 874–882.
- 28, . Flexible implementations of group sequential stopping rules using constrained boundaries. Biometrics 2003; 59(4): 770–777.
- 29Food and Drug Administration. Product information: package insert. Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus b conjugate [tetanus toxoid conjugate] vaccine. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf [29 January 2007].
- 30, , , et al. on behalf of the Pentacel Study Group. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: A randomized, clinical trial. Pediatrics 2009; 123: 301–312. DOI: 10.1542/peds.2007-3317
- 31, , , et al. Near real-time vaccine safety surveillance with partially accrued data. Pharmacoepidemiol Drug Saf 2011; 20(6): 583–590.
- 32, . Discrete Sequential Boundaries for Clinical-Trials. Biometrika 1983; 70(3): 659–663.